Isoniazid hepatotoxicity after orthotopic liver transplantation

Mount Sinai Journal of Medicine

Volumn 63, Issue 5-6, 1996, Pages 364-369

  Schluger, Leona Kim ^a,b   Sheiner, Patricia A ^a   Jonas, Mark ^a   Guarrera, James V ^a   Fiel, Isabel M ^a   Meyers, Burt ^a   Berk, Paul D ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; LIVER TOXICITY; LIVER TRANSPLANTATION; MALE; TUBERCULOSIS;

ADULT; AGED; ANTITUBERCULAR AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS, TOXIC; HUMANS; ISONIAZID; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEW YORK CITY; RETROSPECTIVE STUDIES; RIFAMPIN;

EID: 0029804545     PISSN: 00272507     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Salpeter SR. Fatal isoniazid-induced hepatitis. Its risk during chemoprophylaxis. West J Med 1993; 560-564.
2. Farrell FJ, Keeffee EB, Man KM, et al. Treatment of hepatic failure secondary to isoniazid hepatitis with liver transplantation. Dig Dis Sci 1994; 39:2255-2259.
3. Israel HL, Gottlieb JE, Maddrey WC. Perspective: preventive isoniazid therapy and the liver. Chest 1992; 101: 1298-1301.
4. American Thoracic Society. Treatment of tuberculosis and other mycobacterial diseases. Am Rev Respir Dis 1983; 127:790-796.
5. Thung SN, Gerber MA. Acute hepatitis versus cellular (acute) liver allograft rejection. In: Thung SN, Gerber MA, editors. Differential diagnosis in pathology: liver disorders. New York/Tokyo: Igaku-Shoin, 1995: 920-932.
6. Robitzek EH, Selikoff IJ. Hydrazine derivatives of isonicotinic acid (Rimifon, Marsilid) in the treatment of active progressive caseous-pneumonic tuberculosis. A preliminary report Am Rev Tuberc Pulm Dis 1952; 65: 402-428.
7. Kopanoff DE, Snider DE, Caras GJ. Isomazid-related hepatitis. A U.S. public health service cooperation surveillance study. Am Rev Respir Dis 1978; 117:991-1001.
8. Gabribaldi RA, Drusin RF, Ferebee SH, et al. Isoniazid-associated hepatitis: Report of an outbreak. Am Rev Respir Dis 1972; 106:357-365.
9. Centers for Disease Control. Isoniazid associated hepatitis: summary of the report of the Tuberculosis Advisory Committee and special consultants to the Director. MMWR 1974; 23:97-98.
10. Black M, Mitchell JR, Zimmerman HJ, et al. Isoniazid-associated hepatitis in 114 patients. Gastroenterology 1975; 69:289-302.
11. Maddrey WC, Boitnott JK. Isoniazid hepatitis. Ann Intern Med 1973; 70:1-12.
12. Mitchell JR, Jollow DJ. Metabolic activation of drugs to toxic substances. Gastroenterology 1975; 68:392-410.
13. Steele MA, Burk RF, DesPrez RM. Toxic hepatitis with isoniazid and rifampin: A meta-analysis: Chest 1991; 99:465-471.
14. Matthews J. Pyrazinamide and isoniazid used in the treatment of pulmonary tuberculosis. Am Rev Respir Dis 1960; 81.348-351.
15. Fox W, Mitchison DA. Short course chemotherapy for pulmonary tuberculosis. Am Rev Respir Dis 1975; 111: 325-353.